Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12006300 Sigma ligand compounds and uses thereof

Patent 12006300 was granted and assigned to Minerva Neurosciences on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Minerva Neurosciences

0

Current Assignee

Minerva Neurosciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Nadine Noel0

Hans Maag0

Remy Luthringer0

Sandra Werner0

Jay Saoud0

Florent Schmitt0

Date of Patent

June 11, 2024

0

Patent Application Number

174002070

Date Filed

August 12, 2021

0

Patent Citations

US Patent 10450301 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

0

US Patent 9890172 Inhibitors of histone deacetylase

0

US Patent 7166617 Cyclic amide derivatives

0

US Patent 7446103 Bicyclic benzamide compound as histamine H3 receptor ligand useful in the treatment of neurological diseases

0

US Patent 8962612 Tetrahydroisoquinoline derivative

0

US Patent 9365498 Inhibitors of histone deacetylase

0

US Patent 9447030 Inhibitors of histone deacetylase

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12006300 Sigma ligand compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool